ArticleObesity surgery2025
Predictive Factors for Pulmonary Embolism in Patients Undergoing Metabolic and Bariatric Surgery: Insights from the Latest MBSAQIP Data.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Post-discharge VTE prophylaxis after bariatric surgery: balancing bleeding risk and thrombosis prevention in 275,843 patients.Surgical endoscopy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionObesity is a major risk factor for many diseases, including cardiovascular disease and cancer, among others. While metabolic and bariatric surgery (MBS) is an effective treatment, pulmonary embolism (PE) remains a concern due to factors like Virchow's triad exacerbated by excess adipose tissue. This study aims to identify perioperative risk factors for PE in patients undergoing MBS to help reduce its incidence.
methodsThis study retrospectively analyzed the MBSAQIP PUF database of the year 2023 to identify risk factors for PE within 30 days of sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB).
resultsA total of 200865 MBS patients (133,620 SG, 67,245 RYGB) were included in the study; the incidence of 30-day postoperative PE was 0.1% for SG and 0.12% for RYGB. For SG, significant PE risk factors included age, BMI, Black/African American race, history of PE, immunosuppressive therapy, and heart failure. For RYGB, risk factors were age, Black/African American race, history of PE/VTE, dialysis, need for surgical conversion, and mechanical-only VTE prophylaxis.
conclusionPE is a rare but potentially fatal post-bariatric surgery complication. The most important risk factor was previous history of thromboembolic events in both cohorts. Individualized risk assessment requires further prospective studies.
Indexed as
Identifiers
40889062What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.